Skin temperature can possibly affect the effect of scalp cooling. First a pilot study will be conducted to check the feasibility of the main study. The primary objective of the main study is to identify a cut-off score under which alopecia can be…
ID
Bron
Verkorte titel
Aandoening
Scalp cooling, alopecia, temperature, FEC chemotherapy
Hoofdhuidkoeling, haaruitval, temperatuur, FEC chemotherapie
Ondersteuning
Foreest Medical School
Onderzoeksproduct en/of interventie
Uitkomstmaten
Primaire uitkomstmaten
The pilot study will check the feasibility of the main study, after which specific parameters/outcomes will be defined. Hair loss will be measured asking the patient whether or not a wig or head cover is required, using the World Health Organisation (WHO) grading system and a visual analogue scale (VAS), making pictures and using the trichometer (a diagnostic instrument for measuring changes in hair quantity (mass), hair diameter, and hair density).
Achtergrond van het onderzoek
The primary aim of this study is to assess variations in scalp skin temperature between patients during scalp cooling in the high dose FEC-regimen, thereby improving the results of scalp cooling in the high dose 5Fluorouracil-Epirubicin-Cyclophosphamide (FEC) regimen.
Doel van het onderzoek
Skin temperature can possibly affect the effect of scalp cooling. First a pilot study will be conducted to check the feasibility of the main study. The primary objective of the main study is to identify a cut-off score under which alopecia can be prevented by scalp cooling.
Onderzoeksopzet
N/A
Onderzoeksproduct en/of interventie
N/A
Publiek
Wetenschappelijk
Belangrijkste voorwaarden om deel te mogen nemen (Inclusiecriteria)
1. Patients with breast cancer;
2. Age 18 years or more;
3. Written informed consent;
4. Indication for three to six cycles of intravenous administered 5-Fluorouracil-Epirubicin-Cyclophosphamide (FEC) regimen with an epirubicine dose of 90 mg/m2 or more at 3-weekly intervals.
Belangrijkste redenen om niet deel te kunnen nemen (Exclusiecriteria)
1. Boldness before the start of the study;
2. Clinical signs of scalp metastases;
3. Cold sensitivity;
4. Cold agglutinin disease;
5. Cryoglobulinemia;
6. Cryofibrinogenemia;
7. Cold posttraumatic dystrophy.
Opzet
Deelname
Opgevolgd door onderstaande (mogelijk meer actuele) registratie
Geen registraties gevonden.
Andere (mogelijk minder actuele) registraties in dit register
Geen registraties gevonden.
In overige registers
| Register | ID |
|---|---|
| NTR-new | NL2214 |
| NTR-old | NTR2339 |
| Ander register | METC Noord-Holland : M010-010 |
| ISRCTN | ISRCTN wordt niet meer aangevraagd. |